BMI View: An expected increase in US government funding to strengthen Puerto Rico's healthcare system
will support pharmaceutical and healthcare sector growth in the commonwealth over the next few years.
While the US administration will continue to seek legislative re ..."
BMI View: Despite short-term headwinds due to fiscal tightening, Puerto Rico's pharmaceutical market is
expected to observe modest positive growth over the next five years. This slightly improved outlook already
represents a recovery trend against the negative market ..."
BMI View: There has been very little fluctuation in the forecast for Puerto Rico, indicating that the
country's trajectory has not changed. With an ageing population, caused by decreased birth rates and an
outflow of the country's younger population to the United Stat ..."
BMI View: A downward trend is being witnessed in the Puerto Rican pharmaceutical and healthcare
markets, as key players are being forced to cut back on manufacturing efforts. However,this short-term
hindrance will not impact long-term growth. Furthermore, in facing na ..."
BMI View: The trend of pharmaceutical plant closures in Puerto Rico will lead to increasing
unemployment and deterioration of the island's economy over the short term, as companies are forced to
consolidate their manufacturing operations in the face of financial challenges. In ..."
BMI View: The pharmaceutical manufacturing industry will continue to be an economic mainstay for
Puerto Rico. However, the country is gradually losing attractiveness as a global pharmaceutical production
hub, despite the diversification to the generic and biologic dru ..."
BMI View: The pharmaceutical manufacturing sector will remain an economic mainstay for Puerto Rico.
The local government is focused on defending the commonwealth nation's position as a global
pharmaceutical production hub by offering incentives for the expansion of ex ..."
BMI View: Puerto Rico's struggling economy will continue to put pressure on public healthcare resources,
and we expect only a limited increase in the uptake of pharmaceuticals and medical services in the shortand
medium- term. Given such a background, it is therefore ..."
BMI View: The loss of confidence in the key pharmaceutical sector is expected to impact consumption
levels directly. The fate of the Puerto Rican pharmaceutical market will also remain closely tied to its
economy, given that the US remains its key export partner. Nevertheless, ..."
BMI View: The importance of Puerto Rico as a major production hub for multinational pharmaceutical companies will continue to deteriorate due to drug patent expiration, production quality issues, increasing labour and other operational costs, and the potential tax increase from t ..."